High-level human herpesvirus-8 viremia and multicentric Castleman's disease following initiation of highly active antiretroviral therapy

AIDS

Volumn 28, Issue 11, 2014, Pages 1698-1700

  Lumley, Sheila ^a   Madge, Sara ^a   Nugent, Diarmuid ^b   Ainsworth, Jonathan ^b   Dervisevic, Samir ^c   Schmitt, Corinna ^d   Schulz, Thomas F ^d   Johnson, Margaret A ^a   Cwynarski, Kate ^a   Webster, Daniel P ^a  

^a ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^b NORTH MIDDLESEX UNIVERSITY HOSPITAL NHS TRUST   (United Kingdom)

^c NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; FLUORODEOXYGLUCOSE; IMMUNOGLOBULIN G; RITUXIMAB;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; CASE REPORT; CD4 LYMPHOCYTE COUNT; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; MIXED INFECTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SEROCONVERSION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VIREMIA; VIRUS LOAD; COMPLICATION; GIANT LYMPH NODE HYPERPLASIA; HIV INFECTIONS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY; VIROLOGY;

ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; GIANT LYMPH NODE HYPERPLASIA; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; VIRAL LOAD; VIREMIA;

EID: 84904704956     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000287     Document Type: Letter

References (14)

1. Hoffmann C, Schmid H, Muller M, Teutsch C, van Lunzen J, Esser S, et al. Improved outcome with rituximab in patients with HIV-Associated multicentric Castleman disease. Blood 2011; 118: 3499-3503.
2. Powles T, Stebbing J, Bazeos A, Hatzimichael E, Mandalia S, Nelson M, et al. The role of immune suppression and HHV-8 in the increasing incidence of HIV-Associated multicentric Castleman's disease. Ann Oncol 2009; 20: 775-779.
3. Zietz C, Bogner JR, Goebel FD, Lohrs U. An unusual cluster of cases of Castleman's disease during highly active antiretroviral therapy for AIDS. N Engl J Med 1999; 340: 1923-1924.
4. Lawn SD, Meintjes G. Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy. Expert Rev Anti Infect Ther 2011; 9: 415-430.
5. Feller L, Anagnostopoulos C, Wood NH, Bouckaert M, Raubenheimer EJ, Lemmer J. Human immunodeficiency virusassociated Kaposi sarcoma as an immune reconstitution inflammatory syndrome: a literature review and case report. J Periodontol 2008; 79: 362-368.
6. Muller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M, et al. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-Analysis. Lancet Infect Dis 2010; 10: 251-261.
7. Bourboulia D, Aldam D, Lagos D, Allen E, Williams I, Cornforth D, et al. Short-And long-Term effects of highly active antiretroviral therapy on Kaposi sarcoma-Associated herpesvirus immune responses and viraemia. AIDS 2004; 18: 485-493.
8. Bihl F, Mosam A, Henry LN, Chisholm JV 3rd, Dollard S, Gumbi P, et al. Kaposi's sarcoma-Associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma. AIDS 2007; 21: 1245-1252.
9. Flores R, Goedert JJ. Reconstitution of immune responses against Kaposi sarcoma-Associated herpesvirus. AIDS 2010; 24: 2279-2281.
10. Marcelin AG, Motol J, Guihot A, Caumes E, Viard JP, Dussaix E, et al. Relationship between the quantity of Kaposi sarcomaassociated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-Associated disease. J Infect Dis 2007; 196: 1163-1166.
11. Casper C, Carrell D, Miller KG, Judson FD, Meier AS, Pauk JS, et al. HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: baseline data from the EXPLORE Study. Sex Transm Infect 2006; 82: 229-235.
12. Pauk J, Huang ML, Brodie SJ, Wald A, Koelle DM, Schacker T, et al. Mucosal shedding of human herpesvirus 8 in men.N Engl J Med 2000; 343: 1369-1377.
13. Gantt S, Casper C. Human herpesvirus 8-Associated neoplasms: the roles of viral replication and antiviral treatment. Curr Opin Infect Dis 2011; 24: 295-301.
14. Sayer R, Paul J, Tuke PW, Hargreaves S, Noursadeghi M, Tedder RS, et al. Can plasma HHV8 viral load be used to differentiate multicentric Castleman disease from Kaposi sarcomä Int J STD AIDS 2011; 22: 585-589.